Prospera Financial Services Inc Collegium Pharmaceutical, Inc Transaction History

Prospera Financial Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$14.22 - $20.88 $135,601 - $199,111	-9,536 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$17.2 - $22.5 $164,019 - $214,560	9,536 New	9,536 $194,000
Q4 2020 Feb 12, 2021	SELL	$17.83 - $22.29 $178,371 - $222,989	-10,004 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$15.78 - $20.82 $157,863 - $208,283	10,004 New	10,004 $208,000
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $191,001 - $349,962	-13,751 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$10.7 - $22.24 $147,135 - $305,822	13,751 New	13,751 $283,000

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.